Market Scenario, Clinical Trial Management System (CTMS) Market is expected to grow significantly over the forecast period. The market held a valuation of USD 732.5 Million in 2018 and is projected to account for USD 1,631.3 Million by 2025, registering a CAGR of 12.0% over the forecast period., The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market during the forecast period. , Various other factors, such as the low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market., However, growing clinical trial failure rates and lengthy clinical trial approval time can impede the market growth over the forecast period., Segmentation, The Global Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region. , The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS. , The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS)., On the basis of component, the market has been segmented into software, service, and hardware., The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others., In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa., The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada., The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western

Market Scenario

Clinical Trial Management System (CTMS) Market is expected to grow significantly over the forecast period. The market held a valuation of USD 732.5 Million in 2018 and is projected to account for USD 1,631.3 Million by 2025, registering a CAGR of 12.0% over the forecast period.

The rising frequency of long-lasting diseases and the rapid growth rate of healthcare service benefactors are likely to drive for the growth of the market during the forecast period.

Various other factors, such as the low battery life of mobile computers and reimbursement policies, are also expected to propel the growth of the market.

However, growing clinical trial failure rates and lengthy clinical trial approval time can impede the market growth over the forecast period.

Segmentation

The Global Clinical Trial Management System Market has been segmented based on type, delivery model, component, end user, and region.

The global market for clinical trial management system, by type, has been segmented into enterprise CTMS and on-site CTMS.

The delivery model segment consists of web-based (hosted CTMS), licensed enterprise, and cloud-based CTMS (SaaS).

On the basis of component, the market has been segmented into software, service, and hardware.

The end users of the market have been segmented into pharmaceutical and biopharmaceutical companies, medical device manufacturers, contract research organizations, and others.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The clinical trial management system market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European clinical trial management system market has been segmented into Western Europe and Eastern Europe. Western Europe has been segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The clinical trial management system market in Asia-Pacific has been classified as Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The clinical trial management system market in the Middle East & Africa has been divided into the Middle East and Africa.

Regional Market Summary

Global Clinical Trial Management System Market Share (%), by Region, 2018



Sources: MRFR Analysis

The Americas dominated the global market for a clinical trial management system owing to the increasing investments in research and development of CTMS by major companies and government organizations. In 2019, according to ClinicalTrials.gov database, there were total 322,282 studies registered for clinical trials, wherein and 34% cases registered from the US and 49% from other countries.

In 2018, Europe stood second in the global clinical trial management system market. The growing healthcare IT sector and high accuracy level of information provided by the clinical trial management system is expected to drive the growth of the market. Germany is expected to have the largest share in the European market for clinical trial management systems.

Asia-Pacific is expected to register the fastest growth in clinical trial management system market throughout the forecast period due to the growing customer base for CTMS solutions, growing demand for CMTS in the key markets around the globe, and the favorable government policies for the growth of healthcare IT sector in the region. The increasing sedentary lifestyle is countries in Asia-Pacific fuels the market growth in this region. Moreover, the presence of countries such as China, India, and Japan is expected to have positive impact on the market growth.

On the other hand, the Middle East and Africa held the least share in the global clinical trial management system market due to the lack of awareness and low income, especially within Africa.

Key Players

Some of the key players in the Global Clinical Trial Management System Market are Forte Research Systems Inc., eClinForce, Inc., Oracle, Medidata Solutions, iWeb Technologies, PAREXEL, Bioclinica, Bio-Optronics, IBM, Datatrak, Veeva Systems, DSG, Mastercontrol, ERT, Mednet Solutions, Arisglobal, DZS Software Solutions, and others.

Market Segmentation

Global Clinical Trial Management System Market, by Type



Enterprise CTMS



On-Site CTMS



Global Clinical Trial Management System Market, by Delivery Model



Web-Based (Hosted CTMS)



Licensed Enterprise



Cloud-Based CTMS (SaaS)



Global Clinical Trial Management System Market, by Component



Software



Service



Hardware



Global Clinical Trial Management System Market, by End User



Pharmaceutical and Biopharmaceutical Companies



Medical Device Manufacturers



Contract Research Organizations



Others



Intended Audience



Pharmaceutical Manufacturers and Suppliers



Medical Research Laboratories



Research and Development (R&D) Companies



Contract Research Organizations (CROs)



Government organizations



Independent Research Laboratories



Research and Development (R&D) Companies



Frequently Asked Questions (FAQ) :